Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Sebastian, S, Lambe, T
Formatua:	Journal article
Argitaratua:	MDPI 2018

Antzeko izenburuak

Clinical Advances in Viral-Vectored Influenza Vaccines
nork: Sarah Sebastian, et al.
Argitaratua: (2018-05-01)

Viral vector vaccines
nork: McCann, N, et al.
Argitaratua: (2022)

Clinical development of viral vectored vaccines against MERS-COV
nork: Ewer, K, et al.
Argitaratua: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
nork: D. A. Mezhenskaia, et al.
Argitaratua: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
nork: Bissett, C, et al.
Argitaratua: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
nork: Ewer (nee Russell), K, et al.
Argitaratua: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
nork: Cameron Bissett, et al.
Argitaratua: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
nork: Arunkumar, G, et al.
Argitaratua: (2019)

Research advances in replication-deficient viral vector vaccines
nork: Junna Wang, et al.
Argitaratua: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
nork: McMahon, M, et al.
Argitaratua: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
nork: Antrobus, R
Argitaratua: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
nork: Tully, C, et al.
Argitaratua: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
nork: Tully, C
Argitaratua: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
nork: Mullin, J, et al.
Argitaratua: (2014)

Development of viral vectors for passive immunisation against influenza
nork: Tan, TK
Argitaratua: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
nork: Marta Ulaszewska, et al.
Argitaratua: (2023-01-01)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
nork: Irina Isakova-Sivak, et al.
Argitaratua: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
nork: Antrobus, R, et al.
Argitaratua: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
nork: Antrobus, R, et al.
Argitaratua: (2014)

Adenoviral vectors as novel vaccines for influenza.
nork: Coughlan, L, et al.
Argitaratua: (2015)

Virus-Vectored Influenza Virus Vaccines
nork: Ralph A. Tripp, et al.
Argitaratua: (2014-08-01)

Viral vectors for malaria vaccine development.
nork: Li, S, et al.
Argitaratua: (2007)

The use of viral vectors in vaccine development
nork: Tatianna Travieso, et al.
Argitaratua: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
nork: Kenneth Lundstrom
Argitaratua: (2016-11-01)

Developments in Viral Vector-Based Vaccines
nork: Takehiro Ura, et al.
Argitaratua: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
nork: Ewer (nee Russell), K, et al.
Argitaratua: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
nork: Kapulu, MC
Argitaratua: (2014)

Recombinant influenza A viruses as vaccine vectors
nork: Thomas Gerlach, et al.
Argitaratua: (2019-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
nork: Katie Ewer, et al.
Argitaratua: (2017-12-01)

Viral vectors as vaccine platforms: Deployment in sight
nork: Rollier, C, et al.
Argitaratua: (2011)

Novel viral vector vaccines for tropical infections
nork: Rampling, T
Argitaratua: (2017)

Viral vectors as vaccine platforms: deployment in sight.
nork: Rollier, C, et al.
Argitaratua: (2011)

Viral Vectors for COVID-19 Vaccine Development
nork: Kenneth Lundstrom
Argitaratua: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
nork: Luis Jiménez-Cabello, et al.
Argitaratua: (2020-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
nork: Sushmita Kumari, et al.
Argitaratua: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
nork: Jianfeng Zhang
Argitaratua: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
nork: Shintaro Shichinohe, et al.
Argitaratua: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
nork: L. M. Khantimirova, et al.
Argitaratua: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
nork: McAuliffe, J
Argitaratua: (2020)

Baculovirus expression vector system for production of viral vaccines /
nork: 300419 Vlak, J. M., et al.